API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-5-2023-58407.pdf
https://recalls-rappels.canada.ca/en/alert-recall/endometrin-effervescent-vaginal-tablets-burkholderia-contamination
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11202310416
https://www.europeanpharmaceuticalreview.com/news/177373/utrogestan-approved-as-hrt-in-scotland/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215634
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-17-2021-1637135168.pdf
https://www.pfizercentreone.com/insights-resources/news-updates/pfizer-centerones-envieror-receives-first-eu-authorization-part
http://www.pharmafile.com/news/588612/theramex-pioneers-new-treatment-post-menopausal-women
https://www.fiercepharma.com/pharma/covis-granted-fda-hearing-latest-twist-over-controversial-premature-birth-med-makena
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-pharmascience-pms-progesterone-1629975212.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-18-2021-1629274448.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-bijuva-nda-210132-estradiol-and-progesterone-4-mcg-and-10-mcg-1585974134.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/mankind-pharma-launches-drug-for-treatment-of-infertility-in-india/articleshow/72382986.cms
https://seekingalpha.com/news/3522041-health-canada-review-knights-nds-bijuva
https://endpts.com/embattled-amag-braces-for-october-fda-makena-adcom-but-it-need-not-worry-analyst/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-6-2019-1549474146.pdf
https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-afda-orgs/documents/document/ucm628528.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210965
https://www.biospace.com/article/bayer-halts-enrollment-in-uterine-fibroids-trial/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-21-2018-1542783991.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211285
https://www.reuters.com/article/us-therapeuticsmd-fda-urgent/fda-approves-therapeuticsmds-menopause-drug-idUSKCN1N316U
https://globenewswire.com/news-release/2018/09/05/1565439/0/en/CytoDyn-Announces-Plan-to-Develop-PRO-140-for-Metastatic-Triple-Negative-Breast-Cancer-as-Initial-Oncology-Indication.html
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-August-22-2018-1534903909.pdf
https://endpts.com/catalent-inks-133m-deal-to-buy-juniper-pharmaceuticals-adding-uk-development-services/
https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-appoints-richard-messina-to-board-of-directors-300617302.html
https://www.pfizercentreone.com/apis-intermediates/enviero%E2%84%A2-green-chemistry-progesterone
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-17-2018-1516166737.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205229
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207724
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-5-2017-1499230453.pdf
http://www.thehindubusinessline.com/companies/article9657205.ece?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process
http://www.prnewswire.com/news-releases/juniper-pharmaceuticals-monetizes-us-crinone-royalty-stream-with-allergan-300362725.html
http://raps.org/Regulatory-Focus/News/2016/09/16/25864/EMA-Recommends-Ban-of-US-CMO%E2%80%99s-Medicines/
https://www.pharmacompass.com/pdf/news/akums-drugs-and-pharmaceuticals-fails-edqm-inspections-1465622622.pdf
http://www.prnewswire.com/news-releases/juniper-pharmaceuticals-expands-lead-phase-2b-trial-submits-pre-ind-meeting-request-for-its-first-intra-vaginal-ring-product-and-adds-four-key-executives-300201950.html